Histocompatibility Leukocyte Antigen (HLA)-A*0201 Restricted Peptide Vaccine Therapy in Patients With Esophageal Cancer
Clinical trial NCT00681421 · COMPLETED
Trial details
- NCT number
- NCT00681421
- Sponsor
- Tokyo University
- Status
- COMPLETED
- Phase
- Phase 1, Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2008-05-01
- Primary completion
- 2009-04-01
- Enrollment
- 14
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.